The DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index.
L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE−/− transgenic mice expressing CETP
Open accessAbstract
OBJECTIVE: Dietary l-carnitine can be metabolized by intestinal microbiota to trimethylamine, which is absorbed by the gut and further oxidized to trimethylamine N-oxide (TMAO) in the liver. TMAO plasma levels have been associated with atherosclerosis development in ApoE(-/-) mice. To better understand the mechanisms behind this association, we conducted in vitro and in vivo studies looking at the effect of TMAO on different steps of atherosclerotic disease progression. METHODS: J774 mouse macrophage cells were used to evaluate the effect of TMAO on foam cell formation. Male ApoE(-/-) mice transfected with human cholesteryl ester transfer protein (hCETP) were fed l-carnitine and/or methimazole, a flavin monooxygenase 3 (FMO3) inhibitor that prevents the formation of TMAO. Following 12 week treatment, l-carnitine and TMAO plasma levels, aortic lesion development, and lipid profiles were determined. RESULTS: TMAO at concentrations up to 10-fold the Cmax reported in humans did not affect in vitro foam cell formation. In ApoE(-/-)mice expressing hCETP, high doses of l-carnitine resulted in a significant increase in plasma TMAO levels. Surprisingly, and independently from treatment group, TMAO levels inversely correlated with aortic lesion size in both aortic root and thoracic aorta. High TMAO levels were found to significantly correlate with smaller aortic lesion area. Plasma lipid and lipoprotein levels did not change with treatment nor with TMAO levels, suggesting that the observed effects on lesion area were independent from lipid changes. CONCLUSION: These findings suggest that TMAO slows aortic lesion formation in this mouse model and may have a protective effect against atherosclerosis development in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“even TMAO showed positive effects against atherosclerosis in ApoE−/− transgenic mice expressing cholesteryl ester transfer protein CETP [70].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [70]
In the citing paper
“Feeding L-carnitine to Apo e -/- transgenic mice overexpressing human cholesterol ester transfer protein (CETP) caused increased plasma TMAO concentrations in these mice, but this elevated TMAO was inversely correlated with aortic lesion size (31).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [31]
In the citing paper
“As discussed above in Section 5.1.2,the effects of TMAO on atherogenesis are completely opposite when Apo e -/-transgenic mice overexpressing human CETP are studied.”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [31]
In the citing paper
“In these mice, increased plasma TMAO concentrations were inversely correlated with aortic lesion size (31).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [31]
In the citing paper
“Feeding L-carnitine to Apo e -/- transgenic mice overexpressing human cholesterol ester transfer protein (CETP) caused increased plasma TMAO concentrations in these mice, but this elevated TMAO was inversely correlated with aortic lesion size (31).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [31]
In the citing paper
“On the contrary, Collins et al. showed that TMAO at concentrations up to 10-fold the Cmax reported in humans did not affect in vitro foam cell formation in apoE−/− mice transfected with human cholesteryl ester transfer protein [41].”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [41]
In the citing paper
“Surprisingly, TMAO levels were inversely correlated with atherosclerotic lesion size in aorta.”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [41]
In the citing paper
“In fact, most fish do not contain TMAO, just as most fish do not contain significant amounts of omega-3 fatty acids163,164.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [164]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Markwell, M. A. K., Haas, S. M., BIEBER, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,460
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,765
Research works printed but not linked: 1
- Gulewitsch, 1905, Zur Kenntnis der Extraktionsstoffe der Muskeln. 2. Mitteilungenüber das Carnitin (extracted substances in muscle, report on carnitine), Physiol. Chem., 45
Cited by
Sorted by citations
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163
Postler, T. S., & Ghosh, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.008 · Cited by 876
“Cell Metabolism 26, July 5, 2017 15 Review Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., and Eckhardt, E. (2009).”
BackgroundInfluentialDietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789
Role of gut microbiota in atherosclerosis
Jonsson, A. L., & Bäckhed, F. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 662
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Roy, P., Orecchioni, M., & Ley, K. F. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00584-1 · Cited by 610
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Zhang, L., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 521
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
Microbiota-derived metabolites as drivers of gut–brain communication
Ahmed, H., Leyrolle, Q., Koistinen, V., Kärkkäinen, O., Layé, S., Delzenne, N., & Hanhineva, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2102878 · Cited by 462
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413
Cho, C. E., Taesuwan, S., Malysheva, O. V., Bender, E., Tulchinsky, N. F., Yan, J., Sutter, J. L., & Caudill, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600324 · Cited by 405
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
TMAO: how gut microbiota contributes to heart failure
Zhang, Y., Wang, Y., Ke, B., & Du, J. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.007 · Cited by 311
Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
Ding, L., Chang, M., Guo, Y., Zhang, L., Xue, C., Yanagita, T., Zhang, T., & Wang, Y. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0939-6 · Cited by 250
Liu, Y., & Dai, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/4634172 · Cited by 235
Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13010144 · Cited by 239
The Role of Gut Microbiota in Atherosclerosis and Hypertension
Ma, J., & Li, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01082 · Cited by 234
Hoyles, L., Pontifex, M. G., Rodriguez-Ramiro, I., Anis-Alavi, M. A., Jelane, K. S., Snelling, T., Solito, E., Fonseca, S., Carvalho, A. L., Carding, S. R., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01181-z · Cited by 221
The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
Vourakis, M., Mayer, G., & Rousseau, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158074 · Cited by 233
Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 220
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 218
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Lay, A. L., Dumas, M., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 201
Canyelles, M., Tondo, M., Cedó, L., Farràs, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103228 · Cited by 197
Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
Nam, H. S. (2019) · Journal of Stroke · doi:10.5853/jos.2019.00472 · Cited by 176
Trimethylamine N‐oxide: breathe new life
Subramaniam, S., & Fletcher, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13959 · Cited by 171
Wallace, T. C., Blusztajn, J. K., Caudill, M. A., Klatt, K. C., Natker, E., Zeisel, S. H., & Zelman, K. M. (2018) · Nutrition Today · doi:10.1097/nt.0000000000000302 · Cited by 169
Selma, M. V., González‐Sarrías, A., Salas‐Salvadó, J., Andrés‐Lacueva, C., Alasalvar, C., Örem, A., Tomás-Barberán, F. A., & Espı́n, J. C. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.03.012 · Cited by 168
Alisson-Silva, F., Kawanishi, K., & Varki, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.002 · Cited by 156
Enoki, Y., Watanabe, H., Arake, R., Fujimura, R., Ishiodori, K., Imafuku, T., Nishida, K., Sugimoto, R., Nagao, S., Miyamura, S., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12202 · Cited by 158
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 154
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M. I., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 157
Self-citationHuć, T., Drapała, A., Gawryś-Kopczyńska, M., Konop, M., Maksymiuk, K. M., Zaorska, E., Samborowska, E., Wyczałkowska-Tomasik, A., Pączek, L., Dadlez, M., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00536.2018 · Cited by 134
Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński, A., & Ufnal, M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.001 · Cited by 132
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
Winek, K., Dirnagl, U., & Meisel, A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0475-x · Cited by 108
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Olas, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249737 · Cited by 109
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
Wang, B., Qiu, J., Lian, J., Yang, X., & Zhou, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723886 · Cited by 109
Chan, C. W. H., Law, B. M. H., Waye, M. M. Y., Chan, J. Y., So, W. K. W., & Chow, K. M. (2019) · Journal of Cancer · doi:10.7150/jca.31737 · Cited by 96
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 92
Yao, M., Liao, P., Zhao, X., & Wang, L. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01310-5 · Cited by 90
Gut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 90
Anto, L., & Blesso, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108991 · Cited by 90
Clinical approach to the inflammatory etiology of cardiovascular diseases
Ruscica, M., Corsini, A., Ferri, N., Banach, M., & Sirtori, C. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104916 · Cited by 87
Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality
Kanitsoraphan, C., Rattanawong, P., Charoensri, S., & Senthong, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0252-z · Cited by 89
The gut microbiome and thromboembolism
Hasan, R. A., Koh, A. Y., & Zia, A. N. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.003 · Cited by 86
Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases
Chen, J., Guo, Y., Gui, Y., & Xu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-017-0653-9 · Cited by 89
Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes
Rossner, R., Kaeberlein, M. R., & Leiser, S. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.779678 · Cited by 81
Oktaviono, Y. H., Lamara, A. D., Saputra, P. B. T., Arnindita, J. N., Pasahari, D., Saputra, M. E., & Suasti, N. M. A. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.8893 · Cited by 92
Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide as a Biomarker in Early Parkinson’s Disease
Chung, S. J., Rim, J. H., Ji, D., Lee, S., Yoo, H. S., Jung, J. H., Baik, K., Choi, Y., Ye, B. S., Sohn, Y. H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111090 · Cited by 74
Trimethylamine N -oxide: heart of the microbiota–CVD nexus?
Naghipour, S., Cox, A. J., Peart, J. N., Toit, E. F. D., & Headrick, J. P. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000177 · Cited by 77
Amelioration of TMAO through probiotics and its potential role in atherosclerosis
Din, A. U., Hassan, A., Zhu, Y. S., Yin, T., Gregersen, H. N., & Wang, G. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10142-4 · Cited by 76
Phillips, I. R., & Shephard, E. A. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1643515 · Cited by 72
TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats
Gawryś-Kopczyńska, M., Konop, M., Maksymiuk, K. M., Kraszewska, K., Derzsi, L., Sozański, K., Hołyst, R., Pilz, M., Samborowska, E., Dobrowolski, L., et al. (2020) · eLife · doi:10.7554/elife.57028 · Cited by 67
Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Flaig, B., Garza, R., Singh, B., Hamamah, S., & Covașă, M. (2023) · Nutrients · doi:10.3390/nu15010228 · Cited by 65
Day-Walsh, P. E., Shehata, E., Saha, S., Savva, G. M., Nemeckova, B., Speranza, J., Kellingray, L., Narbad, A., & Kroon, P. A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02572-6 · Cited by 63
Via, A. D., Gargari, G., Taverniti, V., Rondini, G., Velardi, I., Gambaro, V., Visconti, G. L., Vitis, V. D., Gardana, C., Ragg, E. M., et al. (2019) · Nutrients · doi:10.3390/nu12010062 · Cited by 64
Gut microbial metabolites and its impact on human health
Rahman, S. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0809 · Cited by 70
Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD
Li, X., Hong, J. W., Wang, Y., Pei, M., Wang, L., & Gong, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.733507 · Cited by 59
DiNicolantonio, J. J., McCarty, M. F., & O’Keefe, J. H. (2019) · Open Heart · doi:10.1136/openhrt-2018-000890 · Cited by 59
Samulak, J. J., Sawicka, A. K., Hartmane, D., Grı̄nberga, S., Pugovičs, O., Łysiak−Szydłowska, W., & Olek, R. A. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000495037 · Cited by 54
Wahlang, B., Barney, J., Thompson, B., Wang, C., Hamad, O., Hoffman, J. B., Petriello, M. C., Morris, A. J., & Hennig, B. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx180 · Cited by 50
HECKE, T. V., Jakobsen, L. M. A., Vossen, E., Guéraud, F., Vos, F. D., Pierre, F., Bertram, H. C., & SMET, S. D. (2016) · Food & Function · doi:10.1039/c6fo00462h · Cited by 49
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Compositional and functional alterations of gut microbiota in patients with stroke
Xu, D., Wang, K., Yuan, L., Li, H., Xu, Y., Wei, L., Chen, L., Jin, K., & Lin, Q. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.045 · Cited by 45
Chemical hazards in foods of animal origin
Smulders, F. J. M., Rietjens, I. M. C. M., & Rose, M. (2018) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-877-3 · Cited by 48
The Nutraceutical Value of Carnitine and Its Use in Dietary Supplements
Durazzo, A., Lucarini, M., Nazhand, A., Souto, S. B., Silva, A. M., Severino, P. B., Souto, E. B., & Santini, A. (2020) · Molecules · doi:10.3390/molecules25092127 · Cited by 46
Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation
Iglesias‐Carres, L., Hughes, M. D., Steele, C. N., Ponder, M. A., Davy, K. P., & Neilson, A. P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108600 · Cited by 43
Chen, C., Leu, H., Wang, S., Tsai, S., Chou, R., Lu, Y., Tsai, Y., Kuo, C., Huang, P., Chen, J., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0115 · Cited by 41
Krueger, E. S., Lloyd, T. S., & Tessem, J. S. (2021) · Nutrients · doi:10.3390/nu13082873 · Cited by 41
Yoshida, Y., Shimizu, I., Shimada, A., Nakahara, K., Yanagisawa, S., Kubo, M., Fukuda, S., Ishii, C., Yamamoto, H., Ishikawa, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19245-x · Cited by 44
Onyszkiewicz, M., Jaworska, K., & Ufnal, M. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219900898 · Cited by 39
Trimethylamine-N-oxide and its biological variations in vegetarians.
Obeid, R., Awwad, H. M., Keller, M., & Geisel, J. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1295-9 · Cited by 38
TMAO and diabetes: from the gut feeling to the heart of the problem
Jaworska, K., Kuś, M., & Ufnal, M. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00377-8 · Cited by 43
Shi, W., Huang, Y., Zhou, Y., Zhu, L., & Yu, B. (2021) · Bioscience Reports · doi:10.1042/bsr20204250 · Cited by 40
Bordoni, L., Samulak, J. J., Sawicka, A. K., Pelikant‐Małecka, I., Radulska, A., Lewicki, Ł., Kalinowski, L., Gabbianelli, R., & Olek, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75633-1 · Cited by 37
The gut microbiota in thrombosis
Khuu, M. P., Paeslack, N., Dremova, O., Benakis, C., Kiouptsi, K., & Reinhardt, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01070-6 · Cited by 36
Zheng, H. X., Lorenzen, J. K., Astrup, A. V., Larsen, L. H., Yde, C. C., Clausen, M. R., & Bertram, H. C. (2016) · Nutrients · doi:10.3390/nu8030108 · Cited by 33
Querio, G., Antoniotti, S., Levi, R. C., & Gallo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123045 · Cited by 33
Lactobacilli and Bifidobacterium as anti-atherosclerotic agents.
Abdi, M., Ghaleh, H. E. G., & Ranjbar, R. (2022) · PubMed Central · doi:10.22038/ijbms.2022.63860.14073 · Cited by 37
Bjørnestad, E. Ø., Olset, H., Dhar, I., Løland, K. H., Pedersen, E. R., Svingen, G. F. T., Svardal, A. M., Berge, R. K., Ueland, P. M., Tell, G. S., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13067 · Cited by 28
Trimethylamine N-Oxide in Aquatic Foods
Li, X., Wang, C., Yanagita, T., Xue, C., Zhang, T., & Wang, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01974 · Cited by 29
Jaworska, K., Kopacz, W., Koper, M., & Ufnal, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312511 · Cited by 32
Kalagi, N. A., Abbott, K. A., Alburikan, K. A., Alkofide, H., Stojanovski, E., & Garg, M. L. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz012 · Cited by 27
Microbiota-Mediated Immune Regulation in Atherosclerosis
Eshghjoo, S., Jayaraman, A., Sun, Y., & Alaniz, R. C. (2021) · Molecules · doi:10.3390/molecules26010179 · Cited by 29
Bordoni, L., Petracci, I., Pelikant‐Małecka, I., Radulska, A., Piangerelli, M., Samulak, J. J., Lewicki, Ł., Kalinowski, L., Gabbianelli, R., & Olek, R. A. (2021) · The FASEB Journal · doi:10.1096/fj.202100056r · Cited by 26
Bartsch, M., Hahn, A., & Berkemeyer, S. (2023) · Metabolites · doi:10.3390/metabo13121182 · Cited by 28
Senesi, P., Ferrulli, A., Luzi, L., & Terruzzi, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157772 · Cited by 26
Cheng, X., Han, X., Zhou, L., Sun, Y., Zhou, Q., Lin, X., Gao, Z., Wang, J., & Zhao, W. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112942 · Cited by 27
Ganapathy, T. P., Yuan, J.-T., Ho, M. Y.-M., Wu, K. K.-L., Hoque, M. M., Wang, B., Li, X., Wang, K., Wabitsch, M., Feng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63905-1 · Cited by 22
Florentin, M., Elisaf, M., Rizos, C. V., Nikolaou, V., Bilianou, E., Pitsavos, C. E., & Liberopoulos, E. N. (2016) · Lipids · doi:10.1007/s11745-016-4216-z · Cited by 22
Eyileten, C., Jarosz-Popek, J., Jakubik, D., Gąsecka, A., Wolska, M., Ufnal, M., Postula, M. A., Toma, A., Lang, I. M., & Siller-Matula, J. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.728724 · Cited by 22
Metabolomics of Arterial Stiffness
Paapstel, K., & Kals, J. (2022) · Metabolites · doi:10.3390/metabo12050370 · Cited by 23
Impact of red meat consumption on the metabolome of rats
Jakobsen, L. M. A., Yde, C. C., HECKE, T. V., Jessen, R., Young, J. F., SMET, S. D., & Bertram, H. C. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600387 · Cited by 22
Song, J., Huang, M., Shi, X., Li, X., Chen, X., He, Z., Li, J., Xu, G., & Zheng, J. (2021) · Animals · doi:10.3390/ani12010048 · Cited by 21
Taesuwan, S., Vermeylen, F., Caudill, M. A., & Cassano, P. A. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy330 · Cited by 20
Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome
Lent-Schochet, D., Silva, R., McLaughlin, M. J., Huet, B., & Jialal, I. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0015 · Cited by 22
Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease
Zhang, H., Jing, L., Zhai, C., Xiang, Q., Tian, H., & Hu, H. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001387 · Cited by 21
Metadata
- Authors
- Collins, H. L., Drazul-Schrader, D., Sulpizio, A. C., Koster, P. D., Williamson, Y., Adelman, S. J., Owen, K., Sanli, T., & Bellamine, A.
- Affiliations
- Lonza (United States) (US)
- KGK Synergize (Canada) (CA)
- Corresponding author
- Bellamine, Aouatef
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 244
- Pages
- 29-37
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2211887163
- Cited by
- 189
- References
- 64
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 11 · 2023: 14 · 2022: 31 · 2021: 27 · 2020: 22 · 2019: 22 · 2018: 19 · 2017: 13 · 2016: 12
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Atherosclerosis (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- L-carnitine, trimethylamine N-oxide, aortic lesions, ApoE-deficient mice, cholesteryl ester transfer protein, methimazole, flavin monooxygenase 3, gut microbiota, foam cell formation, macrophages
- MeSH terms
- Animals, Apolipoproteins E, Carnitine, Cells, Cultured, Disease Models, Animal, Humans, Macrophages, Male, Methylamines, Mice, Knockout, Disease Progression, Atherosclerosis, Mice, Cholesterol Ester Transfer Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
